Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y014094 | — |
No additional AE reported.; MMR-II was administered to a 4-month-old for travel.; This spontaneous report was received from a physician and refers to a 4-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 11-Sep-2025, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), (lot #Y014094, expiration date: 19-Aug-2026) for prophylaxis, and diluted with sterile diluent (Hollister-Stier STERILE DILUENT), (indication, expiration date, and lot # were not reported) for travel (Product administered to patient of inappropriate age). No additional adverse event was reported.
DILUENT MRK